Fatty acid composition in postmortem brains of people who completed suicide

Journal of Psychiatry and Neuroscience

Volumn 32, Issue 5, 2007, Pages 363-370

  Lalovic, Aleksandra ^a   Levy, Émile ^b   Canetti, Lilian ^a   Sequeira, Adolfo ^a   Montoudis, Alain ^b   Turecki, Gustavo ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Cholesterol; Depression; Fatty acids; Frontal cortext; Lipid metabolism; Suicide

Indexed keywords

OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ARTICLE; BRAIN; GAS CHROMATOGRAPHY; HUMAN; LIPID ANALYSIS; LIPID COMPOSITION; MAJOR DEPRESSION; ORBITAL CORTEX; SUICIDE;

EID: 34848859590     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Golomb BA. Cholesterol and violence: is there a connection? Ann Intern Med 1998;128:478-87.
2. Lalovic A, Turecki G. Cholesterol metabolism and suicidality. Directions in Psychiatry 2006;26:209-17.
3. Virkkunen M. Serum cholesterol in antisocial personality. Neuropsychobiology 1979;5:27-30.
4. Modai I, Valevski A, Dror S, et al. Serum cholesterol levels and suicidal tendencies in psychiatric inpatients. J Clin Psychiatry 1994; 55:252-4.
5. New AS, Sevin EM, Mitropoulou V, et al. Serum cholesterol and impulsivity in personality disorders. Psychiatry Res 1999;85:145-50.
6. Alvarez JC, Cremniter D, Lesieur P, et al. Low blood cholesterol and low platelet serotonin levels in violent suicide attempters. Biol Psychiatry 1999;45:1066-9.
7. Gallerani M, Manfredini R, Caracciolo S, et al. Serum cholesterol concentrations in parasuicide. BMJ 1995;310:1632-6.
8. Kunugi H, Takei N, Aoki H, et al. Low serum cholesterol in suicide attempters. Biol Psychiatry 1997;41:196-200.
9. Garland M, Hickey D, Corvin A, et al. Total serum cholesterol in relation to psychological correlates in parasuicide. Br J Psychiatry 2000;177:77-83.
10. Sarchiapone M, Roy A, Camardese G, et al. Further evidence for low serum cholesterol and suicidal behaviour. J Affect Disord 2000;61:69-71.
11. Hillbrand M, Spitz RT, Foster HG. Serum cholesterol and aggression in hospitalized male forensic patients. J Behav Med 1995;18:33-43.
12. Repo-Tiihonen E, Halonen P, Tiihonen J, et al. Total serum cholesterol level, violent criminal offences, suicidal behavior, mortality and the appearance of conduct disorder in Finnish male criminal offenders with antisocial personality disorder. Eur Arch Psychiatry Clin Neurosci 2002;252:8-11.
13. Virkkunen M. Serum cholesterol levels in homicidal offenders. A low cholesterol level is connected with a habitually violent tendency under the influence of alcohol. Neuropsychobiology 1983;10:65-9.
14. Mufti RM, Balon R, Arfken CL. Low cholesterol and violence. Psychiatr Serv 1998;49:221-4.
15. Lindberg G, Rastam L, Gullberg B, et al. Low serum cholesterol concentration and short term mortality from injuries in men and women. BMJ 1992;305:277-9.
16. Neaton JD, Blackburn H, Jacobs D, et al. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992;152:1490-500.
17. Zureik M, Courbon D, Ducimetiere P. Serum cholesterol concentration and death from suicide in men: paris prospective study I. BMJ 1996;313:649-51.
18. Partonen T, Haukka J, Virtamo J, et al. Association of low serum total cholesterol with major depression and suicide. Br J Psychiatry 1999;175:259-62.
19. Golomb BA, Stattin H, Mednick S. Low cholesterol and violent crime. J Psychiatr Res 2000;34:301-9.
20. Ellison LF, Morrison HI. Low serum cholesterol concentration and risk of suicide. Epidemiology 2001;12:168-72.
21. Muldoon MF, Kaplan JR, Manuck SB, et al. Effects of a low-fat diet on brain serotonergic responsivity in cynomolgus monkeys. Biol Psychiatry 1992;31:739-42.
22. Kaplan JR, Shively CA, Fontenot MB, et al. Demonstration of an association among dietary cholesterol, central serotonergic activity, and social behavior in monkeys. Psychosom Med 1994;56:479-84.
23. Penturk S, Yalcin E. Hypocholesterolaemia in dogs with dominance aggression. J Vet Med A Physiol Pathol Clin Med 2003;50:339-42.
24. Engelberg H. Low serum cholesterol and suicide. Lancet 1992;339:727-9.
25. Mauch DH, Nagler K, Schumacher S, et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001;294:1354-7.
26. Lalovic A, Levy E, Luheshi G, et al. Cholesterol content in brains of suicide completers. Int J Neuropsychopharmacol 2007;10:159-66. Epub 2006 May 17.
27. Tanskanen A, Hibbeln JR, Tuomilehto J, et al. Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv 2001;52:529-31.
28. Huan M, Hamazaki K, Sun Y, et al. Suicide attempt and n-3 fatty acid levels in red blood cells: a case control study in China. Biol Psychiatry 2004;56:490-6.
29. Sublette ME, Hibbeln JR, Galfalvy H, et al. Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am J Psychiatry 2006;163:1100-2.
30. Hakkarainen R, Partonen T, Haukka J, et al. Is low dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry 2004;161:567-9.
31. Adams PB, Lawson S, Sanigorski A, et al. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 1996;31(Suppl):S157-S161.
32. Edwards R, Peet M, Shay J, et al. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 1998;48:149-55.
33. Maes M, Smith R, Christophe A, et al. Fatty acid composition in major depression: decreased omega-3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J Affect Disord 1996;38:35-46.
34. Maes M, Christophe A, Delanghe J, et al. Lowered omega-3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 1999;85:275-91.
35. Peet M, Murphy B, Shay J, et al. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 1998;43:315-9.
36. Parker G, Gibson NA, Brotchie H, et al. Omega-3 fatty acids and mood disorders. Am J Psychiatry 2006;163:969-78.
37. Hibbeln JR. Fish consumption and major depression. Lancet 1998;351:1213.
38. Hibbeln JR. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord 2002;69:15-29.
39. Timonen M, Horrobin D, Jokelainen J, et al. Fish consumption and depression: the northern Finland 1966 birth cohort study. J Affect Disord 2004;82:447-52.
40. Stoll AL, Severus WE, Freeman MP, et al. Omega-3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999;56:407-12.
41. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002;159:477-9.
42. Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 2002;59:913-9.
43. Su KP, Huang SY, Chiu CC, et al. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 2003;13:267-71.
44. Frangou S, Lewis M, McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry 2006;188:46-50.
45. Nemets H, Nemets B, Apter A, et al. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry 2006;163:1098-100.
46. Marangell LB, Martinez JM, Zboyan HA, et al. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 2003;160:996-8.
47. Silvers KM, Woolley CC, Hamilton FC, et al. Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression. Prostaglandins Leufcot Essent Fatty Acids 2005;72:211-8.
48. Keck PE Jr, Mintz J, McElroy SL, et al. Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry 2006;60:1020-2.
49. Alan DD, Clemens F, Elbourne D, et al. A randomised controlled trial investigating the effect of n-3 long-chain polyunsaturated fatty acid supplementation on cognitive and retinal function in cognitively healthy older people: the older people and n-3 long-chain polyunsaturated fatty acids (OPAL) study protocol [ISRCTN72331636]. Nutr J 2006;5:20.
50. Bourre JM. Dietary omega-3 Fatty acids and psychiatry: mood, behaviour, stress, depression, dementia and aging. J Nutr Health Aging 2005;9:31-8.
51. Logan AC. Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression. Altern Med Rev 2003;8:410-25.
52. Kim C, Lesage A, Seguin M, et al. Patterns of co-morbidity in male suicide completers. Psychol Med 2003;33:1299-309.
53. Lesage AD, Boyer R, Grunberg F, et al. Suicide and mental disorders: a case-control study of young men. Am J Psychiatry 1994;151:1063-8.
54. First MB, Spitzer RL, Gibbon M,et al. Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition. (SCIDI/P) New York: Biometrics Research, New York State Psychiatric Institute; 2002.
55. Sequeira A, Gwadry FG. Ffrench-Mullen JM, et al. Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry 2006;63:35-48.
56. Turecki G, Briere R, Dewar K, et al. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am J Psychiatry 1999;156:1456-8.
57. Folch J, Lees M, Sloane Stanley G. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226:497-509.
58. Lepage G, Levy E, Ronco N, et al. Direct transesterification of plasma fatty acids for the diagnosis of essential fatty acid deficiency in cystic fibrosis. J Lipid Res 1989;30:1483-90.
59. Frasure-Smith N, Lesperance F, Julien P. Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol Psychiatry 2004;55:891-6.
60. Julien C, Berthiaume L, Hadj-Tahar A, et al. Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys. Neurochem Int 2006;48:404-14.
61. Skinner ER, Watt C, Besson JA, et al. Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects. Brain 1993;116:717-25.
62. Soderberg M, Edlund C, Kristensson K, et al. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 1991;26:421-5.
63. Dewailly EE, Blanchet C, Gingras S, et al. Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers. Am J Clin Nutr 2001;74:603-11.
64. McNamara RK, Hahn CG, Jandacek R, et al. Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol Psychiatry 2007;62:17-24. Epub 2006 Dec 22
65. Yao JK, Leonard S, Reddy RD. Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients. Schizophr Res 2000;42:7-17.
66. Murphy MG. Dietary fatty acids and membrane protein function. J Nutr Biochem 1990;1:68-79.
67. Wähle KW, Rotondo D, Heys SD. Polyunsaturated fatty acids and gene expression in mammalian systems. Proc Nutr Soc 2003;62:349-60.
68. Alessandri JM, Guesnet P, Vancassel S, et al. Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod Nutr Dev 2004;44:509-38.